Author Archives: admin


Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market to Surge at a Robust Pace in Terms of Revenue Over 2020 to 2025 – News Times

The Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market report by Globalmarketers.Biz sets out the production, consumption, revenue, gross margin, cost, gross, market share, CAGR, and global market influencing factors of the market for 2020-2025. The segmentation of regional market included the historical and forecast mandates for North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market report provides a far-reaching industry analysis by types, applications, players and regions.

Request a Sample PDF Copy of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report Here: https://www.globalmarketers.biz/report/medicine/global-circulating-tumor-cells-(ctcs)-and-cancer-stem-cells-(cscs)-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/132195 #request_sample

The Top Key Players Are Covered In This Report Are As Follows:

JanssenQiagenAdvanced Cell DiagnosticsApoCellBiofluidicaClearbridge BiomedicsCytoTrackCelseeFluxionGilupiCynvenioOn-chipYZY BioBioViewFluidigmIkonisysAdnaGenIVDiagnosticsMiltenyi BiotecScreenCellSilicon Biosystems

Above are the leading companies and brands that are driving the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market. The CAGR numbers are looking quite impressive for the forecast period of 2020-2025 in the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market. The sales, import, export and revenue figures are also skyrocketing in the forecast period. The key players and brands are making their moves by product launches, their researches, their joint ventures, merges, and accusations and are getting successful results. Complete study compiled with over 100+ pages, list of tables & figures, profiling 10+ companies.

Market Segment by Type, covers

CellSearchOthers

Market Segment by Applications, can be divided into

Breast Cancer Diagnosis and TreatmentProstate Cancer Diagnosis and TreatmentColorectal Cancer Diagnosis and TreatmentLung Cancer Diagnosis and TreatmentOther Cancers Diagnosis and Treatment

Market Segment by Regions, regional analysis covers

Enquiry before Buying At https://www.globalmarketers.biz/report/medicine/global-circulating-tumor-cells-(ctcs)-and-cancer-stem-cells-(cscs)-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/132195 #inquiry_before_buying

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report Structure at a Glance:

Reasons to Purchase this Report :

Table of Content:

Get Detailed Table Of Cotents : https://www.globalmarketers.biz/report/medicine/global-circulating-tumor-cells-(ctcs)-and-cancer-stem-cells-(cscs)-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/132195 #table_of_contents

Do You Have Any Question Or Specific Requirement? Ask to Our Industry Expert @ [emailprotected]

Note : You Can Request for the Customisation of Particular Report as per Your Needs. We Ensure You That You Will Get Report As You Want. Thanking You!

More:
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market to Surge at a Robust Pace in Terms of Revenue Over 2020 to 2025 - News Times

Colne woman widowed after husband dies just six months after wedding – LancsLive

A woman from Colne was left widowed after losing her husband to cancer just six months after their wedding.

Emma Smith has told how her husband Scott died after a battle with Hodgkins Lymphoma - a type of blood cancer - in August last year.

The pair - who met in their teens - had got married just six months earlier in March.

The 29-year-old said: "Scott and I met when I was 18 and he was 19, we were both on a night out in Burnley. I remember saying to Scott that I didnt want a boyfriend as I was going away to university in Birmingham and I wasnt going to be coming home every weekend!

"But he said that was fine, and the rest is history."

Just over two years ago, Scott Smith, a 29-year-old firefighter, discovered a lump on his neck.

Due to his dad having recently died from prostate cancer, he was particularly aware of his health and went straight to see his GP.

Emma added: "His GP said it wasnt anything serious. Scott wasnt happy so he went back again and saw the practice manager who told him to come back in six weeks if the lump hadnt gone."

After returning to his GP six weeks later, Scott was referred to hospital for tests which revealed that he had Hodgkins Lymphoma - a type of blood cancer.

Emma said: "We were told that if you get cancer, this is the one you want to get as its so curable and easy to treat. Six months of chemotherapy and then you should be fine.

"Because of this we really thought everything was going to be okay, but things didnt work out that way at all."

A few days after receiving his diagnosis, Scott started chemotherapy and radiotherapy. However, he didnt respond to treatment like doctors had hoped.

This is when the possibility of a stem cell transplant was first mentioned. Despite numerous knock backs, Scott approached the road ahead with positivity and bravery.

The Colne woman explained: "We were told if chemo works, he will need a transplant. That was the dream, a transplant. The chance of a cure."

Emma and Scott had got engaged in 2017 and had their wedding booked for April of last year.

Due to Scotts diagnosis, they took the decision to cancel the wedding in advance, as they thought Scott would be too ill to go ahead with the day.

Emma recalled: "However when we were sat in the hospital one day, we decided to get married. We were madly in love and best friends, we wanted to spend the rest of our lives together.

"Just six weeks later we got married surrounded by our closest friends and family, it was a magical day filled with love and laughter."

Shortly after their wedding, Scott developed a hole between his oesophagus and bronchial, which was caused by the cancer and worsened by the radiotherapy he was having. This resulted in fluid directly entering his lungs and he developed pneumonia after pneumonia.

Emma explained: "At this point we were told that we had two options, stop the radiotherapy and give Scott end of life care or they could attempt to reconstruct Scotts airways, but we were told that he could be in hospital for up to two years and chances are he wont survive.

"So, they gave us two choices but really there was only one."

In April, Scott stopped all treatment and Emma stopped work to care for him.

Emma's sisters, Hannah and Charlie, and the rest of their close family and friends rallied around both her and Scott during this time.

Scott died in August, at the age of 30.

Emma said: "The week before Scott died our friends and family didnt leave the house. Charlie lived in London but came to stay with her boyfriend, Lynas and Hannah was even with Scott when he passed away.

"Im so close to my sisters, we speak numerous [times] a day. Its the little things, Hannah has given me a house key and they took me away between Christmas and New Year, as they knew it was going to be a difficult time.

"The list of things they do for me is endless, Im very lucky. As clich as it sounds, I couldnt have got through it without them.

"I know that Scott took great comfort in knowing I had them by my side."

Before Scott died, Emma talked to him about doing the London Marathon and after asking Hannah and Charlie if they would be up for the challenge, the three of them signed up for the 2020 event together.

They are raising money for the blood cancer charity Anthony Nolan.

The trio call themselves the Hope Runners as they aim to give hope to other people like Scott, who sadly died before he was able to have a stem cell transplant.

Emma claims running has helped her to cope since the passing of her husband.

She said: "Weve set ourselves a big goal for fundraising and training to give us something amazing and positive to focus on in what we know will be the hardest year.

"Weve seen each other through the darkest of times so if we can get through that together, we can get through a marathon."

Anthony Nolan is the charity that finds matching donors for people with blood cancer and gives them a second chance of life.

The charity also carries out ground-breaking research to save more lives and provide information and support to patients after a stem cell transplant.

Anna Scalera, head of events and community at Anthony Nolan, said: We are delighted that the Hope Runners are lacing up her trainers and running theLondon Marathonfor us this year.

"With every mile completed they will be providing hope. The funds they raise will enable us to recruit more potential stem cell donors to the Anthony Nolan register any one of whom could give a second chance of life for someone with blood cancer.

To find out more about The Hope Runners, or to make a donation, click here.

Originally posted here:
Colne woman widowed after husband dies just six months after wedding - LancsLive

Brief respite for Wills in cancer battle – Pentiction Western News

Its Saturday afternoon and nine-year-old Wills Hodgkinson has just returned from visiting a friend. Upstairs in the playroom of his familys Naramata home, his attention is divided between the shiny new Yamaha drum set and the Mighty Ducks movie playing on television.

This is the best part, he said, cranking up the volume on the remote for the critical scene of the show. Its just a really well-made movie, I like the storyline. This is the second Ducks movie, the first one was really good but the third one sucks.

For most kids his age, this would not be anything special. But for Wills, who for the second time in his young life is battling cancer, its anything but typical.

Last week Wills, his father Tim and younger sister Scarlett got to come home from B.C. Childrens Hospital for the first time as a family since late December when Wills had surgery and began chemotherapy again.

But at least for a few days, even with the medical tubes still attached to the outside of his chest, the punishing hospital routine is a lifetime away.

Im feeling really good, its nice to come home and see my friends. I just got back from my best friend Jordans an hour ago and hes coming over tomorrow morning, weve been friends for five years, ever since kindergarten, said Wills with his ever-present smile. Its really great to see my friends, theyve been there to see me at the hospital and its really important that I get to see them again, I miss them.

READ MORE: Nine-year-old Penticton boy fighting cancer with a smile

The other fun thing he got to do on this trip home: I went to school again on two days and saw my other friends and everybody was glad to see me again and they asked about the hospital and I told them some stuff. It was fun.

Wills is in Grade 4 at Holy Cross School and staff and students have been in close touch, even buying him an iPad so they could Facetime back and forth and allowing him to participate in class when hes able.

In Feb. 2018, Wills was diagnosed with a Wilms tumour, a rare kidney cancer that primarily affects children. Then, just before Christmas almost a year past he was cleared two new tumours on his lung were discovered and treatment began all over again, including surgery to remove one of them.

Coming home for Wills has been immense, massive, said his father, Tim. Its so important to have that human contact, for him to sleep in his bed, have his toys, with all the best intentions in the world you cant replace that, theres nothing like it.

Just to let him be part of normal life, he gets to swap being a cancer patient for being a kid again.

Hodgkinson admitted it was with mixed emotions when they walked in the front door of the house last week for the first time since their hasty departure in December. Scarlett, Tim and mom Neeley Brimer have been staying with Wills at B.C. Childrens Hospital as he was treated.

We came home to all our Christmas decorations still being up, our tree had unfortunately lost all its needles and there were unwrapped Christmas presents still waiting. It was a really happy return but it was also kind of a bit sad, he said. But it has really been good for Wills, coming home is not going to be a miracle cure but it does lift a lot of weight. We hope the happier he is the better it will be for him to fight the cancer itself.

READ MORE: Nine-year-old Penticton boy faces return of lung tumours

The three returned to Vancouver Feb. 25 and Wills was expected to undergo a medical evaluation this week and learn his prognosis.

The family is expecting to get those results from the doctors on Friday at the hospital.

This will be one of those hold-the-breath moments, to see how effective the chemo has been on the remaining tumour they deliberately left in, said Hodgkinson, adding Wills could be in for another four, month-long chemo cycles as well as a stem cell implant.

So were in it for the long haul, we know that, just fingers crossed.

Both he and Brimer, who separated in 2016, have been spending time in Vancouver during treatment, Brimer at the hospital with Wills and Scarlett, who is four-and-a-half years old, and Hodgkinson at Ronald McDonald House.

Both parents had immense praise for the enormous support they have received from friends and the many people they dont even know.

Its incredible, in the best possible way its overwhelming, said Brimer. Im incredibly grateful for where we live and the people that are involved in our community.

Cancer

Tim Hodgkinson with his children, Scarlett, 4, and Wills, 9 at their Naramata home. The family has been in Vancouver since late December for Wills cancer treatments. (Mark Brett - Western News)

Wills Hodgkinson, 9, relaxes on the front porch of his Naramata home after being allowed a break in his cancer treatment in Vancouver. (Mark Brett - Western News)

Wills Hodgkinson takes a break from the drums that he got to play again after returning home from B.C. Childrens Hospital for a few days. (Mark Brett - Western News)

Link:
Brief respite for Wills in cancer battle - Pentiction Western News

Review Finds The Effects Of Obesity On The Body Mirror Those Of Aging – IFLScience

Obesity is a widespread health concern affecting around 1.9 billion adults and 380 million children across the globe, with reports from the World Health Organization (WHO) saying that more people are now dying as a result of being overweight than underweight. Obesity has long been known to cause devastation to vital organs and vessels, but new research published in the journal Obesity Reviews highlights how the changes it causes both to our bodies and on a cellular level reflect those of aging.

Obesity increases your risk of developing diseases thatcan dramatically alter your quality of life or even prove fatal. It can cause compromised genomes that increase your risk of cancer and a weakened immune system, making you sicker more often. It also leads to decreased cognition and increases your chances of developing Alzheimer's disease and cardiovascular disease, alongside a host of other illnesses.

The team reviewed over 200 papers looking at the effects of obesity on one'shealth andcells. Weve known for a while that obesity is linked to premature death, but the review also noted the link between obesity and cell death (apoptosis) and the maintenance of healthy cells (autophagy) two processes thatare known to impact physical aging.

"We are trying to comprehensively make the argument that obesity parallels aging," said lead researcher Sylvia Santosa, a Tier II Canada Research Chair in Clinical Nutrition, in a statement. "Indeed, the mechanisms by which the comorbidities of obesity and aging develop are very similar."

One study on various organs of mice including the heart, liver, and kidneys found that apoptosis was increased in clinically obese subjects. Meanwhile, another paper observed that autophagy, which is the bodys way of clearing out unhealthy cells, was negatively impacted, a consequence thatis strongly linked to the emergence of diabetes, Alzheimers, and cardiovascular disease.

Researchers on the review also found obesity can impact our ability to fight off illness as it speeds up the aging of the immune system by targeting different immune cells. These changes not only negatively impacted the bodys ability to fight sickness but also couldnt be reversed by weight loss at a later time. This means obese individuals are at greater risk of picking up bugs like influenza, which are already known to cause more severe symptoms in significantly overweight individuals.

As well as physical changes to our health and cells, aging can be observed at the genetic level as alterations impact the quality of our chromosomes, making them more likely to code for errors and dysfunctional cells. One such example was the shortening of telomeres protective caps thatwere observed to be 25 percent shorter in obese participants when compared to those of a healthy weight.

Scaling up, the review also found that more tangible issues such as cognitive decline, reduced mobility, and increased hypertension and stress all age-related problems associated with later life were seen in obese participants.

The extensive review came about in response to the rising trend of obese children and young adults developing adult-onset conditions such as high cholesterol, diabetes, and hypertension. In a statement, Santosa said, "I ask people to list as many comorbidities of obesity as they can. Then I ask how many of those comorbidities are associated with aging. Most people will say all of them. I'm hoping that these observations will focus our approach to understanding obesity a little more, and at the same time allow us to think of obesity in different ways.

Find out how human stem cells could hold the key to curing diabetes.

Read more:
Review Finds The Effects Of Obesity On The Body Mirror Those Of Aging - IFLScience

Woman of Wellness to hear from San Diego Blood Bank representative – Fallbrook / Bonsall Villlage News

FALLBROOK Woman of Wellness meets Thursday, March 5, at 6 p.m. for San Diego Blood Bank Saving Lives Today, Improving Life Tomorrow at Fallbrook Library, 124 S. Mission Road.

Fallbrook Regional Health Districts Woman of Wellness Program is looking forward to a presentation by Rob Tressler, Ph.D., vice president of laboratories for the San Diego Blood Bank. He oversees the public cord blood bank and cell therapy research program. His scientific focus is in stem cell biology, oncology and anti-aging research. Tressler will discuss how the blood bank is saving lives with traditional blood donation, as well as improving life tomorrow with the stem cell therapy research and other exciting programs.

In addition, FRHD will sponsor a blood drive March 31, at the administrative office, 138 S. Brandon Road, Fallbrook. Watch for details and mark the calendar now as this opportunity to donate blood.

Fallbrook Regional Health District invites men and women to Woman of Wellness each first Thursday of the month, except for this event on the second Thursday. A social time begins at 6 p.m., followed by the presentation at 6:30 p.m. This free event includes refreshments. Donations of non-perishable food items are collected for the Fallbrook Food Pantry.

For more information, call (760) 731-9187.

Submitted by Fallbrook Regional Health District.

See the rest here:
Woman of Wellness to hear from San Diego Blood Bank representative - Fallbrook / Bonsall Villlage News

Michael Everest DeMarco Is Advancing Medical Education By Sponsoring Ground-Breaking Research – GlobeNewswire

Los Angeles, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Dr. Michael Everest through his foundation Everest Foundation is strengthening medical institutions by allocating to them millions of dollars each year to help with effectuating ground-breaking research in stem cell technology, nanotechnology, spinal injuries, and other areas.

Dr. Michael Everest is helping to train the next generation of doctors by providing sponsorships in the form of grants, residency fellowships, research fellowships, and unrestricted long-term gifts. His sponsorships have helped thousands of postdoctoral fellows to pursue cutting-edge medical research that is facilitating important medical breakthroughs.

Michael Everest DeMarco is an Indian-American physician who is the Chairman of the Everest Foundation, a non-profit group dedicated to advancing medical research and education. The Everest Foundation is mainly funded by an endowment from his father Dr. Edwin Everest. It also receives further assistance from several ventures undertaken by Dr. Michael Everest.

The Everest Foundation funds several exciting medical research projects at top medical schools. Michael Everest DeMarco through his foundation supports the SCI and exoskeleton research at the Bronx VA. This is one of the few places in the world where they are doing extensive research on spinal code injuries. Through the efforts of this project, seven men and women who were wheelchair-bound for years were able to walk again.

Among the medical schools supported by the Everest Foundation include New York Medical School, Stanford University, University of Texas, Northwestern University, University of California Davis, University of California-Irvine, and Texas Tech University among others.

The Everest Foundation recently made a 10-year commitment of $1 million to the Keck School of Medicine. This will support medical research for postdoctoral fellows in the Department of Internal Medicine. Dr. Michael Everest made this donation in his father's name in support of medical research and education.

A gift of $162, 500 from Michael Everest DeMarco has already sponsored the first neck and head postdoctoral fellow at the Keck School of Medicine.

The 10-year commitment will also benefit the Children's Hospital of Los Angeles, which is a nonprofit teaching hospital affiliated with the Keck School of Medicine. It will help to support the hospital's global education track.

Medical education is important to Michael Everest DeMarco. He is proud to have made a contribution towards advancing medical education at the Children's Hospital of Los Angeles. As a premier pediatric teaching hospital, medical research is important to innovations in clinical care.

Dr. Michael Everest hopes to ultimately fund global initiatives. This will help train doctors in India and other countries.

A global initiative was recently started at the Children's Hospital of Los Angeles by the Everest Foundation. This will bring foreign doctors from poor countries in Southeast Asia. According to Michael Everest DeMarco, these doctors will be brought to the US and trained on cutting-edge medical technologies and subsequently sent back to their countries. These doctors will be trained to provide improved healthcare in their home countries.

Many foreign medical schools such as those in the Caribbean and East Asia provide "good basic science." However, their graduates lack research experience. That is why Michael Everest DeMarco has undertaken to support international medical graduates by sponsoring them to acquire the research training that they lack.

One of the latest initiatives of Dr. Michael Everest banquet involves supporting pathology training for international medical graduates. He donated $500,000 to the University of California to support this endeavor. This will help Asian Indian graduates and other international graduates. The Davis School of Medicine at the University of California has a large Indian American student population. It is also known for cutting-edge medical research.

The Everest Foundation also supports community-based hospitals in developing countries. These hospitals mainly rely on government funding which is usually not enough. They are not well-financed as private hospitals. By financing community-based hospitals, Dr. Michael Everest aims to enable them to undertake paradigm-changing research that will have a positive impact on the community.

Dr. Everest's philosophy is to support medical education and research with a focus on global health. This is something that is very close to his heart. His mission is to create good patient care in medicine and subsequently to improve the quality of life.

Read more:
Michael Everest DeMarco Is Advancing Medical Education By Sponsoring Ground-Breaking Research - GlobeNewswire

Induced Pluripotent Stem Cells Market Insights on Trends, Application, Types and Users Analysis 2019-2025 – News Times

TMRR in its latest research report states that the global market size of Induced Pluripotent Stem Cells market was $XX million in 2018 with XX CAGR from 2014 to 2018, and is expected to reach $XX million by the end of 2029 with a CAGR of XX% from 2019 to 2029.

Global Induced Pluripotent Stem Cells Market Report 2019 Market Size, Share, Price, Trend and Forecast is an intuitive and exhaustive study on the current and future prospects of the global Induced Pluripotent Stem Cells industry. The key insights are elucidated as under:

Request Sample Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6245&source=atm

There are 4 key segments covered in this report: machine segment, product type segment, end use segment and regional segment.

Competitive landscape of Induced Pluripotent Stem Cells market has tier 1, tier 2 and tier 3 players and provides a dashboard view of their strategies and intensity mapping.

Notable Development

Over the past few years, fast emerging markets in the global induced pluripotent stem cells are seeing the advent of patents that unveil new techniques for reprogramming of adult cells to reach embryonic stage. Particularly, the idea that these pluripotent stem cells can be made to form any cells in the body has galvanized companies to test their potential in human cell lines. Also, a few biotech companies have intensified their research efforts to improve the safety of and reduce the risk of genetic aberrations in their approved human cell lines. Recently, this has seen the form of collaborative efforts among them.

Lineage Cell Therapeutics and AgeX Therapeutics have in December 2019 announced that they have applied for a patent for a new method for generating iPSCs. These are based on NIH-approved human cell lines, and have been undergoing clinical-stage programs in the treatment of dry macular degeneration and spinal cord injuries. The companies claim to include multiple techniques for reprogramming of animal somatic cells.

Such initiatives by biotech companies are expected to impart a solid push to the evolution of the induced pluripotent stem cells.

North America is one of the regions attracting colossal research funding and industry investments in induced pluripotent stem cells technologies. Continuous efforts of players to generate immune-matched supply of pluripotent cells to be used in disease modelling has been a key accelerator for growth. Meanwhile, Asia Pacific has also been showing a promising potential in the expansion of the prospects of the market. The rising number of programs for expanding stem cell-based therapy is opening new avenues in the market.

Customize This Report @ https://www.tmrresearch.com/sample/sample?flag=CR&rep_id=6245&source=atm

For regional segment, the following regions in the Induced Pluripotent Stem Cells market have been covered

Reasons to Purchase this Report:

We also can offer customized report to fulfil special requirements of our clients. Regional and Countries report can be provided as well.

Request For Discount On This Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=6245&source=atm

More:
Induced Pluripotent Stem Cells Market Insights on Trends, Application, Types and Users Analysis 2019-2025 - News Times

Researchers ID Protein-Protein Interaction That Promotes Cancer Development – BioSpace

A group of researchers at Purdue University, led by Humaira Gowher, an associate professor in the Department of Biochemistry, identified an epigenetic process that controls the behavior of stem cell enhancers. In other words, Gowher and her team discovered that the OCT4 protein blocks a sequence of events that occurs when stem cells transition to any cells that arent reproductive cells, otherwise called somatic cells.

What does that mean?

If the cellular mechanisms that control the transition from stem cells to somatic cells don't stop correctly, cells can become cancerous. Gowhers research points to a fundamental mechanism behind why some cells become cancerous.

The research was published in the journal Cell Reports.

If you differentiate normal stem cells, they should silence their pluripotency gene enhancers, but these cells are not doing that, Gowher said. Theyre leaving the enhancer program partially open. Weve uncovered the issue that shelves these cells in some kind of intermediate, rather than in terminally differentiated, state.

In earlier research, Gowhers team found that when normal embryonic stem cells differentiate, they control their stemness genes by silencing certain control elements called enhancers. They do this via DNA methylation, which is a form of epigenetic silencing. A methyl group is a carbon atom with three hydrogen atoms attached to it, and when it is added to certain areas of the genome, acts as a switch, turning genes on or off under certain conditions.

In addition to the DNA methylation, Gowher found that an enzyme called Lsd1 aids in the DNA methylation. In some cancers, the stemness genes are partially repressed, which causes only partial differentiation. One possible way to think of this might be popcorn. If the unpopped popcorn is the stem cell and a fully popped popcorn is the normal somatic cell, the partially popped popcorn is the result of this repression and partial differentiation.

If you differentiate normal stem cells, they should silence their pluripotency gene enhancers, but these cells are not doing that, Gowher said. Theyre leaving the enhancer program partially open. Weve uncovered the issue that shelves these cells in some kind of intermediate, rather than in terminally differentiated, state.

When the enhancers are primed, they may potentially reactivate, which leads to more cell multiplication. This mechanism is also related to why cancer stem cells become resistant to differentiation therapy. Differentiation therapy is a type of cancer treatment where malignant cells are treated with drugs that cause them to differentiate into more mature types. Its because malignant cancer cells usually take on a less specialized, stem cell-like dedifferentiated form.

Another way of looking at it, is that that the fully popped popcorn is susceptible to certain types of cancer drugs, while the partially popped popcorn is less so.

What people have seen in some cancers is that enhancers exist in a primed state, Gowher said. It can potentially help the cancer stem cells survive and propagate. Its a pro-survival mechanism.

The activity of Lsd1 is inhibited by stem cell transcription factor OCT4 in these cells.

Because of this aberrant presence of OCT4, cells arent completely differentiating, Gowher said. If you could inhibit the OCT4-Lsd1 interaction, or target degradation of OCT4, that should allow the cells to differentiate. That could be a target for a cancer therapy.

As their research continues, Gowher will try to determine the interface of Lsd1-OCT4 interaction as well as identify other transcription factors that might inhibit Lsd1 activity.

When embryonic stem cells (ESC) differentiate, pluripotency gene (PpG)-specific enhancers are silenced by way of DNA methylation. The authors note that studies by the Cancer Genome Anatomy Project (CGAP) show that one out of three cancers express PpGs. This suggests they play a role in dysregulated cell proliferation during the formation of tumors, i.e., tumorigenesis. There are other factors as well, but it appears that in order to continue to divide and grow, many cancer cells continue to express PpGs, which led to the development of terminal differentiation therapy.

They wrote, To understand the mechanism by which cancer cells retain PpG expression, we investigated the mechanism of enhancer-mediated regulation of PpG expression in ECCs. Our data showed that, in differentiating F9 ECCs, the PpGs are only partially repressed.

This was consistent with deacetylation of H3K27, the 27th amino acid in Histone H3, a type of protein in the DNA molecule. But it also showed that there was an absence of Lsd1-mediated H3K4me1 demethylation at PpGe.

Which is a fairly complicated and detailed way of saying that they identified a mechanism that causes stem cells to head toward becoming regular somatic cells, but get stuck in an in-between state that can become cancer. And by learning more about this mechanism and targeting it, they may be able to halt cancer proliferation in its tracks.

Read the original here:
Researchers ID Protein-Protein Interaction That Promotes Cancer Development - BioSpace

Dental Regenerative Market Size, Share 2020 Regional Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by…

Global Dental Regenerative Market 2020 Industry Research report provides a comprehensive exploration of vital market dynamics and their recent trends, along with relevant market segments. The Dental Regenerative report also covers several factors influencing the growth of the Dental Regenerative market, Also, its impact on the individual segments is evaluated in this research. The report highlights the regional market, the leading market players, and several market. In addition, the research evaluated key market aspects, comprising capacity utilization rate, revenue, price, capacity, growth rate, gross, production, consumption, supply, export, market share, cost, import, gross margin, demand, and much more. The study also presents the segmentation of the worldwide Dental Regenerative market on the basis of end-users, applications, geography, and technology.

Request a sample copy of the report https://www.marketreportsworld.com/enquiry/request-sample/14366749

The emotional connection of natural teeth and the high nature of natural teeth have drawn attention to the development of bioengineered teeth (tooth regeneration).Tooth regeneration is a stem cell-based regenerative medicine procedure that, in the fields of tissue engineering and stem cell biology, replaces damaged or lost teeth by redrawing from autologous stem cells.As a source of new bioengineered teeth, somatic stem cells are collected and reprogrammed into induced pluripotent stem cells that can be placed directly in the dental plate or in a reabsorbable biopolymer in the shape of a new tooth.Market Analysis and Insights: Global Dental Regenerative MarketIn 2019, the global Dental Regenerative market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.Global Dental Regenerative Scope and Market SizeDental Regenerative market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dental Regenerative market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Global Dental Regenerative market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Dental Regenerative market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Enquire before purchasing this report https://www.marketreportsworld.com/enquiry/pre-order-enquiry/14366749

Global Dental Regenerative market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the TOP PLAYERS including;

The analysis provides an exhaustive investigation of the global Dental Regenerative market together with the future projections to assess the investment feasibility. Furthermore, the report includes both quantitative and qualitative analyses of the Dental Regenerative market throughout the forecast period. The report also comprehends business opportunities and scope for expansion. Besides this, it provides insights into market threats or barriers and the impact of regulatory framework to give an executive-level blueprint the Dental Regenerative market. This is done with an aim of helping companies in strategizing their decisions in a better way and finally attain their business goals.

With tables and figures helping analyze worldwide Global Dental Regenerative market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Purchase this report (Price 3900 USD for a single-user license) https://www.marketreportsworld.com/purchase/14366749

By the product type, the market is primarily split into

By the end users/application, this report covers the following segments

The study objectives of this report are:

In this study, the years considered to estimate the market size of Dental Regenerative are as follows:

Key Stakeholders

Major Points from Table of Contents:

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Dental Regenerative Market Size Growth Rate by Type (2014-2026)

1.4.2 Major-Type

1.4.3 Independent-Type

1.4.4 Administrator-Type

1.5 Market by Application

1.5.1 Global Dental Regenerative Market Share by Application (2014-2026)

1.5.2 Commercial

1.5.3 Commonweal

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Dental Regenerative Market Size

2.2 Dental Regenerative Growth Trends by Regions

2.2.1 Dental Regenerative Market Size by Regions (2014-2026)

2.2.2 Dental Regenerative Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Dental Regenerative Market Size by Manufacturers

3.1.1 Global Dental Regenerative Revenue by Manufacturers (2014-2019)

3.1.2 Global Dental Regenerative Revenue Market Share by Manufacturers (2014-2019)

3.1.3 Global Dental Regenerative Market Concentration Ratio (CR5 and HHI)

3.2 Dental Regenerative Key Players Head office and Area Served

3.3 Key Players Dental Regenerative Product/Solution/Service

3.4 Date of Enter into Dental Regenerative Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Dental Regenerative Market Size by Type (2014-2019)

4.2 Global Dental Regenerative Market Size by Application (2014-2019)

(5, 6, 7, 8, 9, 10, 11) United States, Europe, China, Japan, Southeast Asia, India, Central & South America

Dental Regenerative Market Size (2014-2019)

Key Players

Dental Regenerative Market Size by Type

Dental Regenerative Market Size by Application

12 International Players Profiles

Company Details

Company Description and Business Overview

Dental Regenerative Introduction

Revenue in Dental Regenerative Business (2014-2019)

Recent Development

13 Market Forecast 2019-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2019-2026)

13.10 Market Size Forecast by Application (2019-2026)

14 Analysts Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

Browse complete table of contents at https://www.marketreportsworld.com/TOC/14366749

About Us:

Market Reports Worldis the Credible Source for Gaining the Market Reports that will Provide you with the Lead Your Business Needs. Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided todays businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.

CONTACT US

Name: Ajay More

Read more:
Dental Regenerative Market Size, Share 2020 Regional Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by...

Michael Everest DeMarco Is Advancing Medical Education By Sponsoring Ground-Breaking Research – Yahoo Finance

Los Angeles, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Dr. Michael Everest through his foundation Everest Foundation is strengthening medical institutions by allocating to them millions of dollars each year to help with effectuating ground-breaking research in stem cell technology, nanotechnology, spinal injuries, and other areas.

Dr. Michael Everest is helping to train the next generation of doctors by providing sponsorships in the form of grants, residency fellowships, research fellowships, and unrestricted long-term gifts. His sponsorships have helped thousands of postdoctoral fellows to pursue cutting-edge medical research that is facilitating important medical breakthroughs.

Michael Everest DeMarco is an Indian-American physician who is the Chairman of the Everest Foundation, a non-profit group dedicated to advancing medical research and education. The Everest Foundation is mainly funded by an endowment from his father Dr. Edwin Everest. It also receives further assistance from several ventures undertaken by Dr. Michael Everest.

The Everest Foundation funds several exciting medical research projects at top medical schools. Michael Everest DeMarco through his foundation supports the SCI and exoskeleton research at the Bronx VA. This is one of the few places in the world where they are doing extensive research on spinal code injuries. Through the efforts of this project, seven men and women who were wheelchair-bound for years were able to walk again.

Among the medical schools supported by the Everest Foundation include New York Medical School, Stanford University, University of Texas, Northwestern University, University of California Davis, University of California-Irvine, and Texas Tech University among others.

The Everest Foundation recently made a 10-year commitment of $1 million to the Keck School of Medicine. This will support medical research for postdoctoral fellows in the Department of Internal Medicine. Dr. Michael Everest made this donation in his father's name in support of medical research and education.

A gift of $162, 500 from Michael Everest DeMarco has already sponsored the first neck and head postdoctoral fellow at the Keck School of Medicine.

The 10-year commitment will also benefit the Children's Hospital of Los Angeles, which is a nonprofit teaching hospital affiliated with the Keck School of Medicine. It will help to support the hospital's global education track.

Medical education is important to Michael Everest DeMarco. He is proud to have made a contribution towards advancing medical education at the Children's Hospital of Los Angeles. As a premier pediatric teaching hospital, medical research is important to innovations in clinical care.

Dr. Michael Everest hopes to ultimately fund global initiatives. This will help train doctors in India and other countries.

A global initiative was recently started at the Children's Hospital of Los Angeles by the Everest Foundation. This will bring foreign doctors from poor countries in Southeast Asia. According to Michael Everest DeMarco, these doctors will be brought to the US and trained on cutting-edge medical technologies and subsequently sent back to their countries. These doctors will be trained to provide improved healthcare in their home countries.

Many foreign medical schools such as those in the Caribbean and East Asia provide "good basic science." However, their graduates lack research experience. That is why Michael Everest DeMarco has undertaken to support international medical graduates by sponsoring them to acquire the research training that they lack.

One of the latest initiatives of Dr. Michael Everest banquet involves supporting pathology training for international medical graduates. He donated $500,000 to the University of California to support this endeavor. This will help Asian Indian graduates and other international graduates. The Davis School of Medicine at the University of California has a large Indian American student population. It is also known for cutting-edge medical research.

The Everest Foundation also supports community-based hospitals in developing countries. These hospitals mainly rely on government funding which is usually not enough. They are not well-financed as private hospitals. By financing community-based hospitals, Dr. Michael Everest aims to enable them to undertake paradigm-changing research that will have a positive impact on the community.

Story continues

Dr. Everest's philosophy is to support medical education and research with a focus on global health. This is something that is very close to his heart. His mission is to create good patient care in medicine and subsequently to improve the quality of life.

info@everestfoundation.com

More here:
Michael Everest DeMarco Is Advancing Medical Education By Sponsoring Ground-Breaking Research - Yahoo Finance